vs
Perimeter Solutions, Inc.（PRM）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Perimeter Solutions, Inc.的1.9倍（$197.9M vs $102.8M），REPLIGEN CORP净利率更高（6.7% vs -136.5%，领先143.2%），Perimeter Solutions, Inc.同比增速更快（19.2% vs 13.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $11.6M），过去两年Perimeter Solutions, Inc.的营收复合增速更高（31.9% vs 14.4%）
Perimeter Solutions是一家以色列云与网络安全企业，专为各类机构打造基于零信任架构的安全远程网络方案，其技术可替代VPN、防火墙等传统安全硬件设备，助力企业简化网络安全部署，提升远程访问的安全性与效率。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PRM vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.9倍
$102.8M
营收增速更快
PRM
高出5.5%
13.6%
净利率更高
RGEN
高出143.2%
-136.5%
自由现金流更多
RGEN
多$5.9M
$11.6M
两年增速更快
PRM
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $102.8M | $197.9M |
| 净利润 | $-140.2M | $13.3M |
| 毛利率 | 45.2% | 52.5% |
| 营业利润率 | -160.7% | 9.0% |
| 净利率 | -136.5% | 6.7% |
| 营收同比 | 19.2% | 13.6% |
| 净利润同比 | -197.3% | 143.9% |
| 每股收益（稀释后） | $-0.89 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRMRGEN
| Q4 25 | $102.8M | $197.9M | ||
| Q3 25 | $315.4M | $188.8M | ||
| Q2 25 | $162.6M | $182.4M | ||
| Q1 25 | $72.0M | $169.2M | ||
| Q4 24 | $86.2M | $174.1M | ||
| Q3 24 | $288.4M | $154.9M | ||
| Q2 24 | $127.3M | $154.1M | ||
| Q1 24 | $59.0M | $151.3M |
净利润PRMRGEN
| Q4 25 | $-140.2M | $13.3M | ||
| Q3 25 | $-90.7M | $14.9M | ||
| Q2 25 | $-32.2M | $14.9M | ||
| Q1 25 | $56.7M | $5.8M | ||
| Q4 24 | $144.2M | $-30.3M | ||
| Q3 24 | $-89.2M | $-654.0K | ||
| Q2 24 | $21.6M | $3.3M | ||
| Q1 24 | $-82.6M | $2.1M |
毛利率PRMRGEN
| Q4 25 | 45.2% | 52.5% | ||
| Q3 25 | 63.1% | 53.2% | ||
| Q2 25 | 62.4% | 50.0% | ||
| Q1 25 | 39.1% | 53.6% | ||
| Q4 24 | 48.6% | 26.1% | ||
| Q3 24 | 62.8% | 50.0% | ||
| Q2 24 | 57.6% | 49.8% | ||
| Q1 24 | 35.1% | 49.5% |
营业利润率PRMRGEN
| Q4 25 | -160.7% | 9.0% | ||
| Q3 25 | -27.7% | 8.9% | ||
| Q2 25 | -16.1% | 7.6% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | 71.1% | -17.7% | ||
| Q3 24 | -12.2% | -5.1% | ||
| Q2 24 | 35.4% | 1.0% | ||
| Q1 24 | -126.8% | 1.3% |
净利率PRMRGEN
| Q4 25 | -136.5% | 6.7% | ||
| Q3 25 | -28.7% | 7.9% | ||
| Q2 25 | -19.8% | 8.2% | ||
| Q1 25 | 78.7% | 3.4% | ||
| Q4 24 | 167.2% | -17.4% | ||
| Q3 24 | -30.9% | -0.4% | ||
| Q2 24 | 17.0% | 2.2% | ||
| Q1 24 | -139.8% | 1.4% |
每股收益（稀释后）PRMRGEN
| Q4 25 | $-0.89 | $0.24 | ||
| Q3 25 | $-0.62 | $0.26 | ||
| Q2 25 | $-0.22 | $0.26 | ||
| Q1 25 | $0.36 | $0.10 | ||
| Q4 24 | $1.00 | $-0.55 | ||
| Q3 24 | $-0.61 | $-0.01 | ||
| Q2 24 | $0.14 | $0.06 | ||
| Q1 24 | $-0.57 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $325.9M | $767.6M |
| 总债务越低越好 | $669.1M | $542.2M |
| 股东权益账面价值 | $1.1B | $2.1B |
| 总资产 | $2.7B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.59× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PRMRGEN
| Q4 25 | $325.9M | $767.6M | ||
| Q3 25 | $340.6M | $748.7M | ||
| Q2 25 | $140.7M | $708.9M | ||
| Q1 25 | $200.1M | $697.2M | ||
| Q4 24 | $198.5M | $757.4M | ||
| Q3 24 | $223.1M | $784.0M | ||
| Q2 24 | $43.2M | $809.1M | ||
| Q1 24 | $38.7M | $780.6M |
总债务PRMRGEN
| Q4 25 | $669.1M | $542.2M | ||
| Q3 25 | $668.8M | $537.9M | ||
| Q2 25 | $668.4M | — | ||
| Q1 25 | $668.1M | — | ||
| Q4 24 | $667.8M | $525.6M | ||
| Q3 24 | $667.4M | — | ||
| Q2 24 | $667.1M | — | ||
| Q1 24 | $666.8M | — |
股东权益PRMRGEN
| Q4 25 | $1.1B | $2.1B | ||
| Q3 25 | $1.1B | $2.1B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.2B | $2.0B | ||
| Q4 24 | $1.2B | $2.0B | ||
| Q3 24 | $1.0B | $2.0B | ||
| Q2 24 | $1.1B | $2.0B | ||
| Q1 24 | $1.1B | $2.0B |
总资产PRMRGEN
| Q4 25 | $2.7B | $2.9B | ||
| Q3 25 | $2.6B | $2.9B | ||
| Q2 25 | $2.5B | $2.9B | ||
| Q1 25 | $2.4B | $2.9B | ||
| Q4 24 | $2.4B | $2.8B | ||
| Q3 24 | $2.5B | $2.8B | ||
| Q2 24 | $2.3B | $2.9B | ||
| Q1 24 | $2.3B | $2.8B |
负债/权益比PRMRGEN
| Q4 25 | 0.59× | 0.26× | ||
| Q3 25 | 0.60× | 0.26× | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | 0.58× | 0.27× | ||
| Q3 24 | 0.67× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.63× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | $17.6M |
| 自由现金流率自由现金流/营收 | 11.3% | 8.9% |
| 资本支出强度资本支出/营收 | 6.8% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $208.6M | $93.9M |
8季度趋势，按日历期对齐
经营现金流PRMRGEN
| Q4 25 | $18.6M | $25.7M | ||
| Q3 25 | $198.7M | $48.1M | ||
| Q2 25 | $-2.9M | $28.6M | ||
| Q1 25 | $23.7M | $15.0M | ||
| Q4 24 | $-6.0M | $39.2M | ||
| Q3 24 | $183.0M | $49.3M | ||
| Q2 24 | $8.6M | $42.2M | ||
| Q1 24 | $2.8M | $44.7M |
自由现金流PRMRGEN
| Q4 25 | $11.6M | $17.6M | ||
| Q3 25 | $193.6M | $43.4M | ||
| Q2 25 | $-15.6M | $21.5M | ||
| Q1 25 | $18.9M | $11.4M | ||
| Q4 24 | $-12.4M | $33.6M | ||
| Q3 24 | $179.1M | $42.3M | ||
| Q2 24 | $5.0M | $37.4M | ||
| Q1 24 | $1.2M | $36.4M |
自由现金流率PRMRGEN
| Q4 25 | 11.3% | 8.9% | ||
| Q3 25 | 61.4% | 23.0% | ||
| Q2 25 | -9.6% | 11.8% | ||
| Q1 25 | 26.3% | 6.8% | ||
| Q4 24 | -14.4% | 19.3% | ||
| Q3 24 | 62.1% | 27.3% | ||
| Q2 24 | 3.9% | 24.3% | ||
| Q1 24 | 2.1% | 24.0% |
资本支出强度PRMRGEN
| Q4 25 | 6.8% | 4.1% | ||
| Q3 25 | 1.6% | 2.5% | ||
| Q2 25 | 7.8% | 3.9% | ||
| Q1 25 | 6.7% | 2.1% | ||
| Q4 24 | 7.5% | 3.2% | ||
| Q3 24 | 1.3% | 4.5% | ||
| Q2 24 | 2.9% | 3.1% | ||
| Q1 24 | 2.6% | 5.5% |
现金转化率PRMRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | 0.42× | 2.57× | ||
| Q4 24 | -0.04× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.40× | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRM
| Products | $87.7M | 85% |
| Service And Other | $14.8M | 14% |
RGEN
暂无分部数据
